A phase III trial of Micronised tissue allografts (AmnioFix) for the treatment of plantar fasciitis.

Trial Profile

A phase III trial of Micronised tissue allografts (AmnioFix) for the treatment of plantar fasciitis.

Planning
Phase of Trial: Phase III

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs DHACM (Primary)
  • Indications Plantar fasciitis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 04 Aug 2017 New trial record
    • 02 Aug 2017 According to a MiMedx media release, the comapny anticipates enrolling the first Phase 3 patient within the next 30 to 60 days.
    • 02 Aug 2017 According to a MiMedx media release, the FDA has now accepted a further reduction in the overall follow-up duration for the Phase 3 trial to 6 months, which underlines that the product is safe.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top